HomeCompareTROUF vs MRK

TROUF vs MRK: Dividend Comparison 2026

TROUF yields 10695.19% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TROUF wins by $106959346563748384.00M in total portfolio value
10 years
TROUF
TROUF
● Live price
10695.19%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$106959346563748384.00M
Annual income
$105,027,588,291,011,920,000,000.00
Full TROUF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — TROUF vs MRK

📍 TROUF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTROUFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TROUF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TROUF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TROUF
Annual income on $10K today (after 15% tax)
$909,090.91/yr
After 10yr DRIP, annual income (after tax)
$89,273,450,047,360,130,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, TROUF beats the other by $89,273,450,047,360,130,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TROUF + MRK for your $10,000?

TROUF: 50%MRK: 50%
100% MRK50/50100% TROUF
Portfolio after 10yr
$53479673281874192.00M
Annual income
$52,513,794,145,505,960,000,000.00/yr
Blended yield
98.19%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

TROUF
No analyst data
Altman Z
1.4
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TROUF buys
0
MRK buys
0
No recent congressional trades found for TROUF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTROUFMRK
Forward yield10695.19%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$106959346563748384.00M$56.8K
Annual income after 10y$105,027,588,291,011,920,000,000.00$9,798.13
Total dividends collected$106830944010312400.00M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TROUF vs MRK ($10,000, DRIP)

YearTROUF PortfolioTROUF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$1,080,219$1,069,518.72$11,206$366.19+$1.07MTROUF
2$109,129,118$107,973,283.68$12,650$502.35+$109.12MTROUF
3$10,311,163,641$10,194,395,485.29$14,407$694.19+$10311.15MTROUF
4$911,244,815,536$900,211,870,439.91$16,585$967.82+$911244.80MTROUF
5$75,326,294,709,369$74,351,262,756,745.16$19,342$1,363.89+$75326294.69MTROUF
6$5,824,621,282,878,453$5,744,022,147,539,428.00$22,913$1,947.19+$5824621282.86MTROUF
7$421,332,997,021,045,400$415,100,652,248,365,400.00$27,662$2,823.89+$421332997021.02MTROUF
8$28,513,394,771,231,465,000$28,062,568,464,418,947,000.00$34,159$4,173.35+$28513394771231.43MTROUF
9$1,805,381,563,305,097,200,000$1,774,872,230,899,879,500,000.00$43,337$6,308.80+$1805381563305097.25MTROUF
10$106,959,346,563,748,380,000,000$105,027,588,291,011,920,000,000.00$56,776$9,798.13+$106959346563748384.00MTROUF

TROUF vs MRK: Complete Analysis 2026

TROUFStock

Troubadour Resources Inc. engages in the acquisition, exploration, and evaluation of mineral properties in Canada. The company primarily explores for copper, molybdenum, and gold deposits. The company holds 100% interest in the Amarillo property comprising 9 mineral claims that covers an area of 5,449 hectares located in the west of Peachland. It also holds an option to acquire a 100% interest in the Texas property consisting of 7 mineral claims covering an area of approximately 2,186 hectares located in the Greenwood Mining District in Southern British Columbia. The company was formerly known as Grandore Resources Inc. and changed its name to Troubadour Resources Inc. in February 2017. Troubadour Resources Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Full TROUF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this TROUF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TROUF vs SCHDTROUF vs JEPITROUF vs OTROUF vs KOTROUF vs MAINTROUF vs JNJTROUF vs ABBVTROUF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.